Apixaban plus mono versus dual antiplatelet therapy in acute coronary syndromes: Insights from the APPRAISE-2 trial

Journal of the American College of Cardiology

Volumn 66, Issue 7, 2015, Pages 777-787

  Hess, Connie N ^a   James, Stefan ^b   Lopes, Renato D ^a   Wojdyla, Daniel M ^a   Neely, Megan L ^a   Liaw, Danny ^c   Hagstrom, Emil ^a   Bhatt, Deepak L ^d   Husted, Steen ^e   Goodman, Shaun G ^f   Lewis, Basil S ^g   Verheugt, Freek W A ^h   De Caterina, Raffaele ⁱ   Ogawa, Hisao ^j   Wallentin, Lars ^b   Alexander, John H ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c BRISTOL MYERS SQUIBB   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g CARMEL MEDICAL CENTER   (Israel)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF CHIETI   (Italy)

^j KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

acute coronary syndromes; antiplatelet therapy; antithrombotic therapy apixaban

Indexed keywords

ACETYLSALICYLIC ACID; APIXABAN; CLOPIDOGREL; PLACEBO; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; PURINERGIC P2Y RECEPTOR ANTAGONIST; PYRAZOLE DERIVATIVE; PYRIDONE DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); CLINICAL TRIAL; COMPARATIVE STUDY; DRUG COMBINATION; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

ACUTE CORONARY SYNDROME; AGED; DRUG THERAPY, COMBINATION; FACTOR XA INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; PYRAZOLES; PYRIDONES;

EID: 84939493461     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.06.027     Document Type: Article

References (20)

1. S. Yusuf, F. Zhao, S.R. Mehta, and et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
2. S.D. Wiviott, E. Braunwald, C.H. McCabe, and et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
3. L. Wallentin, R.C. Becker, A. Budaj, and et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
4. P.A. Merlini, K.A. Bauer, L. Oltrona, and et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction Circulation 90 1994 61 68
5. J.L. Mega, E. Braunwald, S.D. Wiviott, and et al. Rivaroxaban in patients with a recent acute coronary syndrome N Engl J Med 366 2012 9 19
6. M.B. Rothberg, C. Celestin, L.D. Fiore, and et al. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit Ann Intern Med 143 2005 241 250
7. J.L. Mega, E. Braunwald, S. Mohanavelu, and et al. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial Lancet 374 2009 29 38
8. J.H. Alexander, R.D. Lopes, S. James, and et al. Apixaban with antiplatelet therapy after acute coronary syndrome N Engl J Med 365 2011 699 708
9. J. Oldgren, A. Budaj, C.B. Granger, and et al. Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial Eur Heart J 32 2011 2781 2789
10. European Medicines Agency Summary of Opinion (post authorization): Xarelto (Rivaroxaban) 2013 European Medicines Agency London, UK Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Summary-of-opinion/human/000944/WC500140679.pdf Accessed November 19, 2014
11. J.H. Alexander, R.D. Lopes, L. Thomas, and et al. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial Eur Heart J 35 2014 224 232
12. J. Oldgren, L. Wallentin, J.H. Alexander, and et al. New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis Eur Heart J 34 2013 1670 1680
13. J.H. Alexander, R.C. Becker, D.L. Bhatt, and et al. Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial Circulation 119 2009 2877 2885
14. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, and et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 485 510
15. H. Jneid, J.L. Anderson, R.S. Wright, and et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines J Am Coll Cardiol 60 2012 645 681
16. C.W. Hamm, J.P. Bassand, S. Agewall, and et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
17. P.G. Steg, S.K. James, D. Atar, and et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
18. W.J. Dewilde, T. Oirbans, F.W. Verheugt, and et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Lancet 381 2013 1107 1115
19. L. Mauri, D.J. Kereiakes, R.W. Yeh, and et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents N Engl J Med 371 2014 2155 2166
20. M.P. Bonaca, D.L. Bhatt, M. Cohen, and et al. Long-term use of ticagrelor in patients with prior myocardial infarction N Engl J Med 372 2015 1791 1800